News in Brief
Health - Oct 25
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research
wire - news in brief
Category
Results 51 - 100 of 420.
Technologies that interfere with our brains have great potential. But their ethical implications are such that they may require an expansion of human rights frameworks, argues Marcello Ienca.
Using heat from underground parking lots to warm apartments
EPFL spin-off Enerdrape has developed technology that can recover heat from underground parking lots and use it to warm the apartments above.
EPFL spin-off Enerdrape has developed technology that can recover heat from underground parking lots and use it to warm the apartments above.
Erster Malaria-Impfstoff von der WHO für Kinder empfohlen
Yesterday, the World Health Organization (WHO) recommended the widespread use of the malaria vaccine RTS,S/AS01, debuting a tool that could save the lives of tens of thousands of children in sub-Saharan Africa each year.
Yesterday, the World Health Organization (WHO) recommended the widespread use of the malaria vaccine RTS,S/AS01, debuting a tool that could save the lives of tens of thousands of children in sub-Saharan Africa each year.
In January 2021, Empa and BASE (Basel Agency for Sustainable Energy) were among the winners of the prestigious Inclusive Growth and Recovery Challenge by data.org, a platform for partnerships committed to build the field of data science for social impact.
Sediments in the Spöl, a small river in the very south of the canton Graubünden, are contaminated with PCBs.
Novartis data show rapid and effective disease activity control with remibrutinib (LOU064) in patients with chronic spontaneous urticaria
Results from a Phase IIb study show all remibrutinib doses provided significant improvements in UAS7 change from baseline at week 4 and week 12 compared to placebo, and a favorable safety profile acr
Results from a Phase IIb study show all remibrutinib doses provided significant improvements in UAS7 change from baseline at week 4 and week 12 compared to placebo, and a favorable safety profile acr
Immersive virtual reality disrupts the child's default coordination strategy, scientists show, something that should be taken into account when developing virtual reality rehabilitation protocols for children. While very little is known on the effects of immersive VR on adults, there is next to no knowledge on the impact of such systems on the sensorimotor abilities of young children.
Wyss Center announces CE mark for its brain data visualization software, Epios Cloud
The cloud-based platform enables long-term brain monitoring towards personalized treatment Geneva, Switzerland - The Wyss Center announced today the CE (Conformité Européenne) mark Class I medical device for its Epios Cloud software.
The cloud-based platform enables long-term brain monitoring towards personalized treatment Geneva, Switzerland - The Wyss Center announced today the CE (Conformité Européenne) mark Class I medical device for its Epios Cloud software.
This new partnership offers Geneva-based start-ups easier access to research laboratories and new funding opportunities.
Novartis data show achieving complete control of chronic spontaneous urticaria (CSU) improves overall quality of life, as reported by patients
Data analysis shows that preventing the symptoms of CSU (achieving complete control) improves overall health-related quality of life (HRQoL); including sleep and work productivity, among other measur
Data analysis shows that preventing the symptoms of CSU (achieving complete control) improves overall health-related quality of life (HRQoL); including sleep and work productivity, among other measur
New data reinforce efficacy and convenience of Novartis Cosentyx (secukinumab) 300 mg autoinjector in adults with psoriasis
New findings show Cosentyx (secukinumab) 300 mg single dose autoinjector (the UnoReady pen) resulted in superior efficacy vs placebo 1 Patient satisfaction with 300 mg autoinjector was high - reachin
New findings show Cosentyx (secukinumab) 300 mg single dose autoinjector (the UnoReady pen) resulted in superior efficacy vs placebo 1 Patient satisfaction with 300 mg autoinjector was high - reachin
Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria
Novartis and Medicines for Malaria Venture (MMV) report positive Phase 2b study results for novel non-artemisinin combination to treat uncomplicated malaria In the Phase 2b study conducted in childre
Novartis and Medicines for Malaria Venture (MMV) report positive Phase 2b study results for novel non-artemisinin combination to treat uncomplicated malaria In the Phase 2b study conducted in childre
Could quantum technologies really be the next gold rush? ETH Vice President Vanessa Wood and quantum researcher Andreas Wallraff discuss how close we are to putting quantum promises into practice.
In conversation with Silvia Scarabelli, PhD, Regulatory and Clinical Affairs Engineer
The 'in conversation' series features members of the Wyss Center community discussing their work, their collaborations and imagining the future.
The 'in conversation' series features members of the Wyss Center community discussing their work, their collaborations and imagining the future.
Two years ago, ETH launched the innovative Master's degree in quantum engineering. Now the first cohort of students is nearing the end of the programme.
Eawag scientist and EPFL professor Urs von Gunten is to receive the prestigious ACS Award for Creative Advances in Environmental Science and Technology.
Scientists have studied two mechanisms that can help bring oxygen to the depths of a lake - essential for preserving the lake's ecosystem.
Two EPFL engineers have come up with a revolutionary new method for tackling plastic pollution by harnessing the inner workings of proteins.
PRISMAP - The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. Nuclear therapy and molecular imaging are widely used at hospitals for new promising medical procedures. They can drastically improve the outcome for many medical conditions and in particular enable the treatment of disseminated cancer.
Switzerland may soon be facing a shortage of railway ballast. ETH geologists are heading into the wilds to track down new sources of crushed rocks.
The Catalyst [email protected] Biotech program, introduced by the Bertarelli Foundation in 2017, aims to support research on innovative treatments for nervous-system diseases.
Solar cells as design objects now adorn the façade above the main entrance to the NEST building of Empa and Eawag.
Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients
Acute respiratory infections are one of the leading causes of death and disability globally, presenting substantial health challenges especially for infants, the elderly and the immunocompromised.
Acute respiratory infections are one of the leading causes of death and disability globally, presenting substantial health challenges especially for infants, the elderly and the immunocompromised.
At the Bassenges Farm, six devoted women and men are bringing their vision of sustainability to the EPFL and UNIL campuses, giving low-tech agriculture - without pesticides - a chance to thrive.
New WHO Air Quality Guidelines Aim to Save Millions of Lives from Air Pollution
Today, the World Health Organization launched their new Global Air Quality Guidelines, which aims to protect the health of populations by reducing key air pollutants.
Today, the World Health Organization launched their new Global Air Quality Guidelines, which aims to protect the health of populations by reducing key air pollutants.
From genetics and personalised medicine to health insurance and climate change: at ETH Week 2021, 120 students from all degree programmes and from 31 countries grappled with the topic of "Health for Tomorrow".
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced bre
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced bre
News in Brief
Health - Oct 25
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research
Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research